UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Options (right to buy) | (1) | 05/11/2026 | Common Shares | 120,000 | $ 1.6 (2) | D | |
Options (right to buy) | (3) | 11/21/2027 | Common Shares | 150,000 | $ 2.25 (2) | D | |
Options (right to buy) | (4) | 03/02/2028 | Common Shares | 150,000 | $ 3.56 (2) | D | |
Options (right to buy) | (5) | 08/06/2029 | Common Shares | 1,671,711 | $ 7.5 (2) | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Maslow Randy C/O IANTHUS CAPITAL HOLDINGS, INC. 420 LEXINGTON AVENUE, SUITE 414 NEW YORK, NY 10170 |
X | Interim CEO and President |
/s/ Julius Kalcevich as Attorney-In-Fact for Randy Maslow | 02/05/2021 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | On May 11, 2016, the Issuer granted the Reporting Person options to purchase up to 120,000 common shares. As of the date hereof, all options have vested in full. |
(2) | The exercise price is denominated and reported in Canadian Dollars. |
(3) | On November 21, 2017, the Issuer granted the Reporting Person options to purchase up to 150,000 common shares. As of the date hereof, all options have vested in full. |
(4) | On March 2, 2018, the Issuer granted the Reporting Person options to purchase up to 150,000 common shares. As of the date hereof, all options have vested in full. |
(5) | On August 6, 2019, the Issuer granted the Reporting Person options to purchase up to 1,671,711 common shares, which options are subject to vesting upon the achievement of certain milestones. As of the date hereof, 1,044,000 options have vested in full. Assuming milestones are achieved as of each quarter end, the balance of the options will vest as follows: 125,541 options on March 31, 2021; 129,543 options on June 30, 2021; 125,542 options on September 30, 2021; 125,542 options on December 31, 2021; and 124,543 stock options on March 31, 2022. |
Remarks: Exhibit List: Exhibit 24 - Power of Attorney |